Facultad de Enfermería y Terapia Ocupacional
Cáceres, 10003, Spain
NCT Number: NCT07292311
This research aims to evaluate the reliability and reproducibility of muscle strength and activation measurement tools, including isokinetic dynamometry and surface electromyography, in patients with chronic kidney disease (CKD). Additionally, the study will assess the feasibility and potential benefits of an online therapeutic exercise program supervised by physiotherapists.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Cáceres, 10003, Spain
Patients with chronic kidney disease experience progressive muscle weakness and reduced physical capacity due to systemic inflammation, metabolic acidosis, and inactivity.
This two-phase observational and interventional study, conducted in collaboration with the ALCER Association (Badajoz and Cáceres, Spain), will:
The project aims to provide valid and reliable protocols for neuromuscular assessment in CKD patients and explore the feasibility of remote therapeutic exercise.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Device: Isokinetic dynamometer and mDurance® surface EMG Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb
Behavioral: Online therapeutic exercise program 8-10 week supervised online program including resistance and mobility exercises
Time frame: 7-10 days
RMS (root mean square). microvolts
Time frame: 7-10 days
Intraclass Correlation Coefficient - ICC. Strength (kilograms)
Time frame: Baseline and 12 weeks
strength (kilograms)
University of Extremadura
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06329622
Atrophy, Chronic Disease
Shanghai, China
View Trial DetailsNCT07437053
Atrophy, Chronic Disease
San Antonio, Texas, United States
View Trial DetailsNCT07102667
Atrophy, Chronic Disease
Bangkok, Thailand
View Trial DetailsNCT03579693
Atrophy, Chronic Disease
Seattle, Washington, United States
View Trial Details